Melanocortin Receptor 4 Market, Global Outlook and Forecast 2022-2028

Melanocortin Receptor 4 Market, Global Outlook and Forecast 2022-2028

Report Code: KNJ1281356 | No. of Pages: 66 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2022
This report contains market size and forecasts of Melanocortin Receptor 4 in Global, including the following market information:
Global Melanocortin Receptor 4 Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Melanocortin Receptor 4 market was valued at  million in 2021 and is projected to reach US$  million by 2028, at a CAGR of  % during the forecast period.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
Bremelanotide Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Melanocortin Receptor 4 include AstraZeneca Plc, Mallinckrodt Plc, Obexia AG, Palatin Technologies, Inc., Pfizer Inc., Retrophin Inc. and Rhythm Pharmaceuticals, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Melanocortin Receptor 4 companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Melanocortin Receptor 4 Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Melanocortin Receptor 4 Market Segment Percentages, by Type, 2021 (%)
    Bremelanotide
    Corticotropin
    Cosyntropin
    Others
Global Melanocortin Receptor 4 Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Melanocortin Receptor 4 Market Segment Percentages, by Application, 2021 (%)
    Metabolic Disorder
    Women's Health
    Genito Urinary System
    Infection Disease
    Others
Global Melanocortin Receptor 4 Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Melanocortin Receptor 4 Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Melanocortin Receptor 4 revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Melanocortin Receptor 4 revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    AstraZeneca Plc
    Mallinckrodt Plc
    Obexia AG
    Palatin Technologies, Inc.
    Pfizer Inc.
    Retrophin Inc.
    Rhythm Pharmaceuticals, Inc.
1 Introduction to Research & Analysis Reports
    1.1 Melanocortin Receptor 4 Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Melanocortin Receptor 4 Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Melanocortin Receptor 4 Overall Market Size
    2.1 Global Melanocortin Receptor 4 Market Size: 2021 VS 2028
    2.2 Global Melanocortin Receptor 4 Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Melanocortin Receptor 4 Players in Global Market
    3.2 Top Global Melanocortin Receptor 4 Companies Ranked by Revenue
    3.3 Global Melanocortin Receptor 4 Revenue by Companies
    3.4 Top 3 and Top 5 Melanocortin Receptor 4 Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Melanocortin Receptor 4 Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Melanocortin Receptor 4 Players in Global Market
        3.6.1 List of Global Tier 1 Melanocortin Receptor 4 Companies
        3.6.2 List of Global Tier 2 and Tier 3 Melanocortin Receptor 4 Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Melanocortin Receptor 4 Market Size Markets, 2021 & 2028
        4.1.2 Bremelanotide
        4.1.3 Corticotropin
        4.1.4 Cosyntropin
        4.1.5 Others
    4.2 By Type - Global Melanocortin Receptor 4 Revenue & Forecasts
        4.2.1 By Type - Global Melanocortin Receptor 4 Revenue, 2017-2022
        4.2.2 By Type - Global Melanocortin Receptor 4 Revenue, 2023-2028
        4.2.3 By Type - Global Melanocortin Receptor 4 Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Melanocortin Receptor 4 Market Size, 2021 & 2028
        5.1.2 Metabolic Disorder
        5.1.3 Women's Health
        5.1.4 Genito Urinary System
        5.1.5 Infection Disease
        5.1.6 Others
    5.2 By Application - Global Melanocortin Receptor 4 Revenue & Forecasts
        5.2.1 By Application - Global Melanocortin Receptor 4 Revenue, 2017-2022
        5.2.2 By Application - Global Melanocortin Receptor 4 Revenue, 2023-2028
        5.2.3 By Application - Global Melanocortin Receptor 4 Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Melanocortin Receptor 4 Market Size, 2021 & 2028
    6.2 By Region - Global Melanocortin Receptor 4 Revenue & Forecasts
        6.2.1 By Region - Global Melanocortin Receptor 4 Revenue, 2017-2022
        6.2.2 By Region - Global Melanocortin Receptor 4 Revenue, 2023-2028
        6.2.3 By Region - Global Melanocortin Receptor 4 Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Melanocortin Receptor 4 Revenue, 2017-2028
        6.3.2 US Melanocortin Receptor 4 Market Size, 2017-2028
        6.3.3 Canada Melanocortin Receptor 4 Market Size, 2017-2028
        6.3.4 Mexico Melanocortin Receptor 4 Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Melanocortin Receptor 4 Revenue, 2017-2028
        6.4.2 Germany Melanocortin Receptor 4 Market Size, 2017-2028
        6.4.3 France Melanocortin Receptor 4 Market Size, 2017-2028
        6.4.4 U.K. Melanocortin Receptor 4 Market Size, 2017-2028
        6.4.5 Italy Melanocortin Receptor 4 Market Size, 2017-2028
        6.4.6 Russia Melanocortin Receptor 4 Market Size, 2017-2028
        6.4.7 Nordic Countries Melanocortin Receptor 4 Market Size, 2017-2028
        6.4.8 Benelux Melanocortin Receptor 4 Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Melanocortin Receptor 4 Revenue, 2017-2028
        6.5.2 China Melanocortin Receptor 4 Market Size, 2017-2028
        6.5.3 Japan Melanocortin Receptor 4 Market Size, 2017-2028
        6.5.4 South Korea Melanocortin Receptor 4 Market Size, 2017-2028
        6.5.5 Southeast Asia Melanocortin Receptor 4 Market Size, 2017-2028
        6.5.6 India Melanocortin Receptor 4 Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Melanocortin Receptor 4 Revenue, 2017-2028
        6.6.2 Brazil Melanocortin Receptor 4 Market Size, 2017-2028
        6.6.3 Argentina Melanocortin Receptor 4 Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Melanocortin Receptor 4 Revenue, 2017-2028
        6.7.2 Turkey Melanocortin Receptor 4 Market Size, 2017-2028
        6.7.3 Israel Melanocortin Receptor 4 Market Size, 2017-2028
        6.7.4 Saudi Arabia Melanocortin Receptor 4 Market Size, 2017-2028
        6.7.5 UAE Melanocortin Receptor 4 Market Size, 2017-2028
7 Players Profiles
    7.1 AstraZeneca Plc
        7.1.1 AstraZeneca Plc Corporate Summary
        7.1.2 AstraZeneca Plc Business Overview
        7.1.3 AstraZeneca Plc Melanocortin Receptor 4 Major Product Offerings
        7.1.4 AstraZeneca Plc Melanocortin Receptor 4 Revenue in Global Market (2017-2022)
        7.1.5 AstraZeneca Plc Key News
    7.2 Mallinckrodt Plc
        7.2.1 Mallinckrodt Plc Corporate Summary
        7.2.2 Mallinckrodt Plc Business Overview
        7.2.3 Mallinckrodt Plc Melanocortin Receptor 4 Major Product Offerings
        7.2.4 Mallinckrodt Plc Melanocortin Receptor 4 Revenue in Global Market (2017-2022)
        7.2.5 Mallinckrodt Plc Key News
    7.3 Obexia AG
        7.3.1 Obexia AG Corporate Summary
        7.3.2 Obexia AG Business Overview
        7.3.3 Obexia AG Melanocortin Receptor 4 Major Product Offerings
        7.3.4 Obexia AG Melanocortin Receptor 4 Revenue in Global Market (2017-2022)
        7.3.5 Obexia AG Key News
    7.4 Palatin Technologies, Inc.
        7.4.1 Palatin Technologies, Inc. Corporate Summary
        7.4.2 Palatin Technologies, Inc. Business Overview
        7.4.3 Palatin Technologies, Inc. Melanocortin Receptor 4 Major Product Offerings
        7.4.4 Palatin Technologies, Inc. Melanocortin Receptor 4 Revenue in Global Market (2017-2022)
        7.4.5 Palatin Technologies, Inc. Key News
    7.5 Pfizer Inc.
        7.5.1 Pfizer Inc. Corporate Summary
        7.5.2 Pfizer Inc. Business Overview
        7.5.3 Pfizer Inc. Melanocortin Receptor 4 Major Product Offerings
        7.5.4 Pfizer Inc. Melanocortin Receptor 4 Revenue in Global Market (2017-2022)
        7.5.5 Pfizer Inc. Key News
    7.6 Retrophin Inc.
        7.6.1 Retrophin Inc. Corporate Summary
        7.6.2 Retrophin Inc. Business Overview
        7.6.3 Retrophin Inc. Melanocortin Receptor 4 Major Product Offerings
        7.6.4 Retrophin Inc. Melanocortin Receptor 4 Revenue in Global Market (2017-2022)
        7.6.5 Retrophin Inc. Key News
    7.7 Rhythm Pharmaceuticals, Inc.
        7.7.1 Rhythm Pharmaceuticals, Inc. Corporate Summary
        7.7.2 Rhythm Pharmaceuticals, Inc. Business Overview
        7.7.3 Rhythm Pharmaceuticals, Inc. Melanocortin Receptor 4 Major Product Offerings
        7.7.4 Rhythm Pharmaceuticals, Inc. Melanocortin Receptor 4 Revenue in Global Market (2017-2022)
        7.7.5 Rhythm Pharmaceuticals, Inc. Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com